19 insiders reported 210 Form 4 transactions for Mineralys Therapeutics, Inc. (MLYS) over the past 18 months (most recent 2026-08-12). Recent activity: Ferguson James J. III (Chief Medical Officer) Buy 102,400 shares, Rodman David Malcom (Chief Medical Officer) Buy 2,170 shares, Rodman David Malcom (Chief Medical Officer) Sell 2,170 shares, Warren Eric (Chief Commercial Officer) Buy 7,438 shares, Warren Eric (Chief Commercial Officer) Sell 7,438 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | Ferguson James J. III | Chief Medical Officer | Buy | 102,400 | $0 |
| 2026-08-12 | Rodman David Malcom | Chief Medical Officer | Buy | 2,170 | $34,720 |
| 2026-08-12 | Rodman David Malcom | Chief Medical Officer | Sell | 2,170 | $58,785 |
| 2026-07-23 | Warren Eric | Chief Commercial Officer | Buy | 7,438 | $98,479 |
| 2026-07-23 | Warren Eric | Chief Commercial Officer | Sell | 7,438 | $199,885 |
| 2026-07-20 | Rodman David Malcom | Chief Medical Officer | Buy | 416 | $6,423 |
| 2026-07-20 | Rodman David Malcom | Chief Medical Officer | Sell | 416 | $11,036 |
| 2026-07-15 | Rodman David Malcom | Chief Medical Officer | Sell | 6,349 | $168,955 |
| 2026-07-15 | Rodman David Malcom | Chief Medical Officer | Buy | 3,542 | $36,128 |
| 2026-07-15 | Rodman David Malcom | Chief Medical Officer | Buy | 4,167 | $59,380 |
| 2026-07-15 | Rodman David Malcom | Chief Medical Officer | Buy | 6,349 | $6,857 |
| 2026-07-15 | Rodman David Malcom | Chief Medical Officer | Sell | 14,058 | $387,717 |
| 2026-07-15 | Congleton Jon | Chief Executive Officer | Sell | 10,700 | $291,441 |
| 2026-07-10 | Rodman David Malcom | Chief Medical Officer | Buy | 2,171 | $34,736 |
| 2026-07-10 | Rodman David Malcom | Chief Medical Officer | Sell | 2,171 | $65,781 |
| 2026-06-30 | Congleton Jon | Chief Executive Officer | Sell | 58,000 | $1.5M |
| 2026-06-30 | Congleton Jon | Chief Executive Officer | Sell | 17,000 | $455,896 |
| 2026-06-30 | Warren Eric | Chief Commercial Officer | Sell | 104,124 | $2.7M |
| 2026-06-30 | Warren Eric | Chief Commercial Officer | Buy | 104,124 | $1.4M |
| 2026-06-17 | Rodman David Malcom | Chief Medical Officer | Buy | 417 | $6,438 |
| 2026-06-17 | Rodman David Malcom | Chief Medical Officer | Buy | 3,542 | $36,128 |
| 2026-06-17 | Karydas Daphne | Director | Buy | 3,000 | $36,060 |
| 2026-06-17 | Rodman David Malcom | Chief Medical Officer | Sell | 9,890 | $235,487 |
| 2026-06-17 | Karydas Daphne | Director | Sell | 3,000 | $75,000 |
| 2026-06-17 | Rodman David Malcom | Chief Medical Officer | Buy | 4,167 | $59,380 |
Source: SEC Form 4 filings · as of 2026-08-12